Our research targets infectious disease, autoimmunity, cardiovascular disease, mental health, cancer and inherited disease by understanding the underlying molecular drivers. This includes immune, inflammatory, metabolic and signaling processes, these fundamental pathways are shared across multiple diseases. This helps us to understand the drivers of human health and disease.
Latest publications
CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer
Journal article
Rajamanickam V. et al, (2026), Translational Oncology, 66, 102690 - 102690
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial
Journal article
Blanc-Durand F. et al, (2026), Clinical Cancer Research, 32, 963 - 969